| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,314 |
20,922 |
$17.15M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,878 |
13,745 |
$10.40M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,797 |
6,243 |
$5.20M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,792 |
4,553 |
$3.45M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,013 |
2,852 |
$2.54M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,308 |
1,257 |
$915K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
865 |
807 |
$665K |
| 99218 |
|
2,595 |
1,182 |
$267K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,917 |
1,198 |
$264K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,421 |
1,365 |
$189K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,580 |
1,561 |
$169K |
| 99221 |
|
1,015 |
636 |
$151K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,524 |
7,226 |
$110K |
| 0002A |
|
2,227 |
2,136 |
$89K |
| 0001A |
|
2,208 |
2,099 |
$87K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,221 |
963 |
$84K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,635 |
1,157 |
$54K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
880 |
863 |
$50K |
| 71046 |
Radiologic examination, chest; 2 views |
6,441 |
6,147 |
$44K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,329 |
2,188 |
$44K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
513 |
494 |
$38K |
| 87186 |
|
2,184 |
1,681 |
$37K |
| 76830 |
Ultrasound, transvaginal |
1,054 |
994 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,082 |
8,593 |
$30K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
791 |
371 |
$29K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
26 |
25 |
$29K |
| 76642 |
|
569 |
502 |
$28K |
| 97161 |
|
569 |
524 |
$28K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,260 |
1,190 |
$28K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,959 |
1,083 |
$27K |
| 0071A |
|
610 |
561 |
$23K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,326 |
1,282 |
$23K |
| 0072A |
|
566 |
536 |
$22K |
| 0004A |
|
531 |
511 |
$21K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,381 |
1,686 |
$20K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,149 |
3,666 |
$20K |
| 76536 |
|
491 |
480 |
$19K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,001 |
482 |
$18K |
| 0054A |
|
374 |
364 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,578 |
10,230 |
$15K |
| 76770 |
|
294 |
289 |
$14K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
18 |
16 |
$14K |
| 73562 |
|
1,611 |
1,376 |
$11K |
| 73610 |
|
1,393 |
1,262 |
$11K |
| 73630 |
|
1,837 |
1,588 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,670 |
3,256 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
190 |
97 |
$10K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,206 |
971 |
$9K |
| 73030 |
|
1,271 |
1,136 |
$9K |
| 96160 |
|
13,679 |
12,445 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
119 |
112 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
27 |
25 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,448 |
1,399 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,722 |
1,978 |
$7K |
| 73110 |
|
714 |
641 |
$7K |
| 77066 |
Tomosynthesis, mammo |
91 |
87 |
$7K |
| 70496 |
|
66 |
61 |
$6K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
16 |
14 |
$6K |
| 73130 |
|
1,316 |
1,121 |
$6K |
| 0064A |
|
148 |
142 |
$6K |
| 87075 |
|
703 |
599 |
$6K |
| 71250 |
|
62 |
53 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,245 |
5,499 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
689 |
591 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
28 |
25 |
$4K |
| 93975 |
|
45 |
44 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
55 |
51 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
12 |
$3K |
| 11045 |
|
16 |
12 |
$3K |
| 0052A |
|
77 |
76 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,196 |
2,019 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
96 |
92 |
$3K |
| 70498 |
|
41 |
38 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
5,752 |
5,345 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,327 |
2,598 |
$2K |
| 20610 |
|
108 |
99 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
337 |
264 |
$2K |
| 93017 |
|
89 |
82 |
$2K |
| 72100 |
|
207 |
204 |
$2K |
| 93246 |
|
131 |
127 |
$2K |
| 99215 |
Prolong outpt/office vis |
191 |
137 |
$2K |
| 70486 |
|
43 |
37 |
$1K |
| 0051A |
|
36 |
35 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,261 |
814 |
$1K |
| 77065 |
Tomosynthesis, mammo |
74 |
69 |
$1K |
| 64615 |
|
12 |
12 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,754 |
1,120 |
$1K |
| 92557 |
|
43 |
36 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,180 |
2,120 |
$976.79 |
| 96161 |
|
2,744 |
2,637 |
$877.00 |
| 80053 |
Comprehensive metabolic panel |
4,954 |
4,526 |
$846.21 |
| 73502 |
|
57 |
53 |
$837.17 |
| 99205 |
Prolong outpt/office vis |
75 |
66 |
$831.46 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,361 |
13,784 |
$504.26 |
| 82962 |
|
5,506 |
3,636 |
$472.89 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,660 |
1,085 |
$394.50 |
| 73080 |
|
88 |
84 |
$386.04 |
| 87077 |
|
1,068 |
644 |
$358.21 |
| 72110 |
|
12 |
12 |
$305.73 |
| 93976 |
|
230 |
216 |
$289.32 |
| 70491 |
|
17 |
13 |
$257.96 |
| 73090 |
|
64 |
61 |
$203.57 |
| 73140 |
|
78 |
72 |
$180.64 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
852 |
478 |
$145.27 |
| 87807 |
|
865 |
833 |
$136.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,486 |
5,116 |
$134.00 |
| 74019 |
|
12 |
12 |
$129.57 |
| 74018 |
|
13 |
12 |
$127.20 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,235 |
4,215 |
$102.62 |
| 87070 |
|
1,304 |
1,127 |
$92.01 |
| 73590 |
|
91 |
82 |
$77.52 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,914 |
3,701 |
$76.90 |
| 86850 |
|
1,042 |
972 |
$74.19 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,658 |
16,887 |
$73.44 |
| 84134 |
|
15 |
13 |
$65.20 |
| 81025 |
|
6,919 |
6,335 |
$38.68 |
| 87040 |
|
2,372 |
1,204 |
$32.61 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
435 |
412 |
$28.78 |
| 80076 |
|
6,790 |
6,232 |
$23.28 |
| 84702 |
|
480 |
449 |
$21.84 |
| 85610 |
|
3,063 |
2,829 |
$14.97 |
| 87088 |
|
1,250 |
1,108 |
$13.66 |
| 86140 |
|
1,322 |
1,224 |
$11.43 |
| 83735 |
|
766 |
621 |
$9.72 |
| 81001 |
|
10,118 |
9,399 |
$9.18 |
| 81002 |
|
3,320 |
3,155 |
$7.48 |
| 36415 |
Collection of venous blood by venipuncture |
910 |
621 |
$3.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,143 |
4,746 |
$1.34 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,202 |
1,531 |
$0.00 |
| 85379 |
|
1,114 |
1,063 |
$0.00 |
| 82803 |
|
1,697 |
1,352 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
545 |
481 |
$0.00 |
| 87205 |
|
1,248 |
1,074 |
$0.00 |
| 83605 |
|
2,707 |
2,133 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
949 |
818 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,849 |
1,517 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,418 |
2,008 |
$0.00 |
| 96376 |
|
510 |
454 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,332 |
2,917 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
2,231 |
1,941 |
$0.00 |
| 83880 |
|
2,171 |
1,975 |
$0.00 |
| 83690 |
|
6,818 |
6,264 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,973 |
2,839 |
$0.00 |
| 85730 |
|
2,597 |
2,430 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
726 |
680 |
$0.00 |
| 84484 |
|
7,381 |
5,211 |
$0.00 |
| 85027 |
|
631 |
591 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
37 |
28 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
636 |
597 |
$0.00 |
| 86901 |
|
1,342 |
1,249 |
$0.00 |
| 85652 |
|
813 |
751 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
342 |
329 |
$0.00 |
| 82330 |
|
502 |
453 |
$0.00 |
| 82150 |
|
92 |
87 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
759 |
751 |
$0.00 |
| 84703 |
|
977 |
930 |
$0.00 |
| 80320 |
|
15 |
15 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
399 |
371 |
$0.00 |
| 84132 |
|
505 |
469 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
100 |
95 |
$0.00 |
| 87081 |
|
190 |
186 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
175 |
153 |
$0.00 |
| J3490 |
Unclassified drugs |
89 |
72 |
$0.00 |
| 80329 |
|
14 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
35 |
25 |
$0.00 |
| 92567 |
|
29 |
25 |
$0.00 |
| 88304 |
|
26 |
24 |
$0.00 |
| 82550 |
|
26 |
25 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
14 |
12 |
$0.00 |
| 86900 |
|
1,323 |
1,231 |
$0.00 |
| 85014 |
|
1,523 |
1,406 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
156 |
145 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,886 |
5,015 |
$0.00 |
| 82565 |
|
1,768 |
1,680 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,291 |
1,973 |
$0.00 |
| 84295 |
|
449 |
417 |
$0.00 |
| 90715 |
|
313 |
289 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
932 |
796 |
$0.00 |
| 84145 |
|
956 |
884 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
60 |
57 |
$0.00 |
| 82947 |
|
260 |
244 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
392 |
375 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
193 |
184 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
75 |
73 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
644 |
607 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
239 |
145 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
210 |
206 |
$0.00 |
| 87210 |
|
43 |
43 |
$0.00 |
| 29125 |
|
16 |
16 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
33 |
33 |
$0.00 |
| 94799 |
|
118 |
95 |
$0.00 |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
37 |
36 |
$0.00 |
| 12011 |
|
13 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
17 |
14 |
$0.00 |